Depression and suicidality in obese patients
David Lester1, Paolo Iliceto, Maurizio Pompili
1The Richard Stockton College of New Jersey, USA.
Psychological Reports
|June 17, 2011
Summary
Obese patients frequently experience severe depression and suicidal risk. Healthcare providers should screen for these mental health conditions in this population.
Area of Science:
- Clinical Psychology
- Obesity Medicine
- Psychiatry
Background:
- Obesity is a complex health issue associated with various comorbidities.
- Mental health conditions, such as depression, are increasingly recognized as significant factors in obesity.
- The interplay between obesity, depression, and suicidality requires further clinical attention.
Purpose of the Study:
- To investigate the prevalence of severe depression and suicidal risk among obese patients.
- To highlight the clinical implications of these findings for healthcare professionals.
Main Methods:
- A cohort of 70 obese patients was assessed.
- Standardized diagnostic criteria were likely used to evaluate for depression and suicidal risk (specifics not detailed in abstract).
Main Results:
- Severe depression was identified in 32% of the studied obese patients.
- A notable 23% of the sample exhibited some level of suicidal risk.
- These findings indicate a high prevalence of mental health concerns within this group.
Conclusions:
- The study underscores a significant association between obesity and mental health issues, specifically depression and suicidality.
- Health professionals must proactively assess obese patients for depression and suicidal ideation.
- Early identification and intervention are crucial for managing the holistic health of individuals with obesity.
Related Concept Videos
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ā„ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:30Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...